LinkedIn Profile

Access OnCore Biopharma historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:oncorebiopharma 5224789 Feb 17th, 2018 12:00AM OnCore BioPharma Inc. 272 5.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM OnCore BioPharma Inc. merged with Tekmira Pharmaceuticals Corp. on March 4, 2015. Effective August 3, 2015, Tekmira Pharmaceuticals Corporation changed its corporate name to Arbutus Biopharma Corporation (“Arbutus”, ticker symbol “ABUS”), an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV). The name change affirms the successful integration of OnCore BioPharma and Tekmira Pharmaceuticals into a combined company with the goal of delivering a cure for chronic HBV. For more information please refer to www.arbutusbio.com OnCore Biopharma Health Care Equipment & Services
private:oncorebiopharma 5224789 Feb 16th, 2018 12:00AM OnCore BioPharma Inc. 272 5.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM OnCore BioPharma Inc. merged with Tekmira Pharmaceuticals Corp. on March 4, 2015. Effective August 3, 2015, Tekmira Pharmaceuticals Corporation changed its corporate name to Arbutus Biopharma Corporation (“Arbutus”, ticker symbol “ABUS”), an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV). The name change affirms the successful integration of OnCore BioPharma and Tekmira Pharmaceuticals into a combined company with the goal of delivering a cure for chronic HBV. For more information please refer to www.arbutusbio.com OnCore Biopharma Health Care Equipment & Services
private:oncorebiopharma 5224789 Feb 15th, 2018 12:00AM OnCore BioPharma Inc. 272 5.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM OnCore BioPharma Inc. merged with Tekmira Pharmaceuticals Corp. on March 4, 2015. Effective August 3, 2015, Tekmira Pharmaceuticals Corporation changed its corporate name to Arbutus Biopharma Corporation (“Arbutus”, ticker symbol “ABUS”), an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV). The name change affirms the successful integration of OnCore BioPharma and Tekmira Pharmaceuticals into a combined company with the goal of delivering a cure for chronic HBV. For more information please refer to www.arbutusbio.com OnCore Biopharma Health Care Equipment & Services
private:oncorebiopharma 5224789 Feb 14th, 2018 12:00AM OnCore BioPharma Inc. 272 5.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM OnCore BioPharma Inc. merged with Tekmira Pharmaceuticals Corp. on March 4, 2015. Effective August 3, 2015, Tekmira Pharmaceuticals Corporation changed its corporate name to Arbutus Biopharma Corporation (“Arbutus”, ticker symbol “ABUS”), an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV). The name change affirms the successful integration of OnCore BioPharma and Tekmira Pharmaceuticals into a combined company with the goal of delivering a cure for chronic HBV. For more information please refer to www.arbutusbio.com OnCore Biopharma Health Care Equipment & Services
private:oncorebiopharma 5224789 Feb 13th, 2018 12:00AM OnCore BioPharma Inc. 272 5.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM OnCore BioPharma Inc. merged with Tekmira Pharmaceuticals Corp. on March 4, 2015. Effective August 3, 2015, Tekmira Pharmaceuticals Corporation changed its corporate name to Arbutus Biopharma Corporation (“Arbutus”, ticker symbol “ABUS”), an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV). The name change affirms the successful integration of OnCore BioPharma and Tekmira Pharmaceuticals into a combined company with the goal of delivering a cure for chronic HBV. For more information please refer to www.arbutusbio.com OnCore Biopharma Health Care Equipment & Services
private:oncorebiopharma 5224789 Feb 12th, 2018 12:00AM OnCore BioPharma Inc. 272 5.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM OnCore BioPharma Inc. merged with Tekmira Pharmaceuticals Corp. on March 4, 2015. Effective August 3, 2015, Tekmira Pharmaceuticals Corporation changed its corporate name to Arbutus Biopharma Corporation (“Arbutus”, ticker symbol “ABUS”), an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV). The name change affirms the successful integration of OnCore BioPharma and Tekmira Pharmaceuticals into a combined company with the goal of delivering a cure for chronic HBV. For more information please refer to www.arbutusbio.com OnCore Biopharma Health Care Equipment & Services
private:oncorebiopharma 5224789 Feb 11th, 2018 12:00AM OnCore BioPharma Inc. 272 5.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM OnCore BioPharma Inc. merged with Tekmira Pharmaceuticals Corp. on March 4, 2015. Effective August 3, 2015, Tekmira Pharmaceuticals Corporation changed its corporate name to Arbutus Biopharma Corporation (“Arbutus”, ticker symbol “ABUS”), an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV). The name change affirms the successful integration of OnCore BioPharma and Tekmira Pharmaceuticals into a combined company with the goal of delivering a cure for chronic HBV. For more information please refer to www.arbutusbio.com OnCore Biopharma Health Care Equipment & Services
private:oncorebiopharma 5224789 Feb 10th, 2018 12:00AM OnCore BioPharma Inc. 272 5.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM OnCore BioPharma Inc. merged with Tekmira Pharmaceuticals Corp. on March 4, 2015. Effective August 3, 2015, Tekmira Pharmaceuticals Corporation changed its corporate name to Arbutus Biopharma Corporation (“Arbutus”, ticker symbol “ABUS”), an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV). The name change affirms the successful integration of OnCore BioPharma and Tekmira Pharmaceuticals into a combined company with the goal of delivering a cure for chronic HBV. For more information please refer to www.arbutusbio.com OnCore Biopharma Health Care Equipment & Services
private:oncorebiopharma 5224789 Feb 9th, 2018 12:00AM OnCore BioPharma Inc. 272 5.00 Open Biotechnology Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM OnCore BioPharma Inc. merged with Tekmira Pharmaceuticals Corp. on March 4, 2015. Effective August 3, 2015, Tekmira Pharmaceuticals Corporation changed its corporate name to Arbutus Biopharma Corporation (“Arbutus”, ticker symbol “ABUS”), an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV). The name change affirms the successful integration of OnCore BioPharma and Tekmira Pharmaceuticals into a combined company with the goal of delivering a cure for chronic HBV. For more information please refer to www.arbutusbio.com OnCore Biopharma Health Care Equipment & Services
private:oncorebiopharma 5224789 Feb 8th, 2018 12:00AM OnCore BioPharma Inc. 272 5.00 Open Biotechnology Feb 8th, 2017 11:57AM Feb 8th, 2017 11:57AM OnCore BioPharma Inc. merged with Tekmira Pharmaceuticals Corp. on March 4, 2015. Effective August 3, 2015, Tekmira Pharmaceuticals Corporation changed its corporate name to Arbutus Biopharma Corporation (“Arbutus”, ticker symbol “ABUS”), an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV). The name change affirms the successful integration of OnCore BioPharma and Tekmira Pharmaceuticals into a combined company with the goal of delivering a cure for chronic HBV. For more information please refer to www.arbutusbio.com OnCore Biopharma Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.